A drug trial to evaluate the safety and efficacy of daratumumab, an agent already approved for other diseases, in combination with standard background anti-rheumatic therapy in patients with moderate-to-severe systemic lupus erythematosus A drug trial to evaluate the safety and efficacy of daratumumab, an agent already approved for other ...
A Monocenter, Open Label Study to Evaluate the Safety and Efficacy of Daratumumab in Combination with Standard Background Therapy in Participants with Moderate to Severe Systemic Lupus Erythematosus - DARALUP A Monocenter, Open Label Study to Evaluate the Safety and Efficacy of Daratumumabin Combination with ...
An Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus Erythematosus An Open Label Study to Evaluate Daratumumabin Participants With Moderate to Severe Systemic Lupus Er ...
A Monocenter, Open Label Study to Evaluate the Safety and Efficacy of Daratumumab in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus A Monocenter, Open Label Study to Evaluate the Safety and Efficacy of Daratumumabin Combination With ...